TACC3 overexpression in cholangiocarcinoma correlates with poor progno
- This topic has 0 replies, 1 voice, and was last updated 7 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.
https://www.ncbi.nlm.nih.gov/pubmed/27705912
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.